Label: FLUSH MAXIMUM STRENGTH ANTIFUNGAL FORMULA- undecylenic acid liquid
- NDC Code(s): 80569-084-15
- Packager: Triple Point Group, LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated November 11, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- DRUG FACTS:
- Active Ingredient
- Uses:
- Warnings:
-
Directions:
- Clean and dry affected area with soap and water and dry throughly.
- Apply a thin layer to the affected area twice daily (morning and night) or as directed by physician.
- For athletes foot, pay special attention to the space between the toes, and wear well-fitting ventilated shoes and socks. For athlete's foot and ringworm. If Conditions persists for longer, consult a physician.
- Intended for use typically by healthy adults only. Persons under the age of 18, or those with highly sensitive or allergic skin should use only as directed by physician.
- This product is not meant to be applied directly to the Scalp or nails.
- Other ingredients:
- Package Labeling
-
INGREDIENTS AND APPEARANCE
FLUSH MAXIMUM STRENGTH ANTIFUNGAL FORMULA
undecylenic acid liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:80569-084 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength UNDECYLENIC ACID (UNII: K3D86KJ24N) (UNDECYLENIC ACID - UNII:K3D86KJ24N) UNDECYLENIC ACID 250 mg in 1 mL Inactive Ingredients Ingredient Name Strength CITRONELLA OIL (UNII: QYO8Q067D0) LAVENDER OIL (UNII: ZBP1YXW0H8) TEA TREE OIL (UNII: VIF565UC2G) ALMOND OIL (UNII: 66YXD4DKO9) JOJOBA OIL (UNII: 724GKU717M) CLOVE OIL (UNII: 578389D6D0) .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:80569-084-15 15 mL in 1 BOTTLE, GLASS; Type 0: Not a Combination Product 09/17/2020 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M005 09/17/2020 Labeler - Triple Point Group, LLC (058482713)